Patent · US Active

Treatment of immune disease by mucosal delivery of antigens using genetically modified Lactococcus

US10143729B2 · kind B2 · utility

0Cited by

38References

33Claims

0Family size

Assignee

INTREXON ACTOBIOTICS N.V. · BE

Inventors

Pieter Rottiers · Zevergem, BE
Veerle Snoeck · Zingem, BE

Key dates

Filing date	Aug 5, 2013
Grant date	Dec 4, 2018
Priority date	—
Expiry date	Aug 5, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12R2001/225
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to the treatment of autoimmune and allergic diseases by mucosal delivery by micro-organism, in particular Lactococcus lactis, of secreted immunodominant antigens.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.